SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (42)11/1/2000 1:38:53 PM
From: tuck  Read Replies (1) | Respond to of 1784
 
Peter,

Thanks. Note the presence of GZTC in the watch list. IGEN selling off suddenly in advance of earnings. The Trickle Portfolio is sorely tempted to nibble here. Thoughts?

Cheers, Tuck



To: Biomaven who wrote (42)11/1/2000 2:09:41 PM
From: keokalani'nui  Respond to of 1784
 
Further Re ILXO. Campath will be reviewed at the 12/14 ODAC and will be the subject of not less than 12 abstracts at the ASH December meeting. The company is an interesting proxy on many cancer therapeutics, but as Peter notes that's where all the air is, so check it out...but its not for trickle.

--Wilder


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News